95 related articles for article (PubMed ID: 11357224)
1. The prognostic value of the expression of collagenase IV, cathepsin D and metallothionein in squamous cell carcinomas of the skin determined by immunohistochemistry.
Goldmann T; Moorkamp A; Wiedorn KH; Suter L; Otto F
Arch Dermatol Res; 2001 Mar; 293(3):115-20. PubMed ID: 11357224
[TBL] [Abstract][Full Text] [Related]
2. The expression of proteolytic enzymes at the dermal invading front of primary cutaneous melanoma predicts metastasis.
Goldmann T; Suter L; Ribbert D; Otto F
Pathol Res Pract; 1999; 195(3):171-5. PubMed ID: 10220797
[TBL] [Abstract][Full Text] [Related]
3. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics.
Goldmann T; Ribbert D; Suter L; Brode M; Otto F
J Exp Clin Cancer Res; 1998 Dec; 17(4):483-9. PubMed ID: 10089072
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis and prognostic value of cathepsin D determination in laryngeal squamous cell carcinoma.
Seiwerth S; Stambuk N; Konjevoda P; Masić N; Vasilj A; Bura M; Klapan I; Manojlović S; Danić D
J Chem Inf Comput Sci; 2000; 40(3):545-9. PubMed ID: 10850757
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Cathepsin D in Primary and Recurrent Squamous Cell Carcinoma.
Satelur KP; Kumar GS
J Contemp Dent Pract; 2017 Sep; 18(9):795-801. PubMed ID: 28874644
[TBL] [Abstract][Full Text] [Related]
6. Prognostic classification of malignant melanomas by combining clinical, histological, and immunohistochemical parameters.
Otto FJ; Goldmann T; Biess B; Lippold A; Suter L; Westhoff U
Oncology; 1999 Apr; 56(3):208-14. PubMed ID: 10202276
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein immunolocalization in actinic skin nonmelanoma carcinomas.
Borges Júnior PC; Ribeiro RI; Cardoso SV; Berbet AL; Rocha A; Espindola FS; Loyola AM
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):165-9. PubMed ID: 17525628
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
10. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
[TBL] [Abstract][Full Text] [Related]
11. Expression of cathepsin D and B in invasion and metastasis of squamous cell carcinoma.
Kawada A; Hara K; Kominami E; Hiruma M; Akiyama M; Ishibashi A; Abe H; Ichikawa E; Nakamura Y; Watanabe S; Yamamoto T; Umeda T; Nishioka K
Br J Dermatol; 1997 Sep; 137(3):361-6. PubMed ID: 9349330
[TBL] [Abstract][Full Text] [Related]
12. [Cytosolic cathepsin D levels in squamous carcinomas of the lung].
Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF
Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.
Goussia A; Ioachim E; Peschos D; Assimakopoulos D; Vougiouklakis T; Skevas A; Agnantis N
Anticancer Res; 1999; 19(4B):3055-60. PubMed ID: 10652592
[TBL] [Abstract][Full Text] [Related]
15. Nm23 and cathepsin D expression in laryngeal carcinomas.
Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin-D and tumor associated antigen DF3 in salivary gland neoplasia. Differential diagnostic and prognostic applications.
Vigneswaran N; Müller S; DeRose P; Cohen C
Pathol Res Pract; 1994 Dec; 190(12):1174-84. PubMed ID: 7540754
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
20. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.
Szumilo J; Burdan F; Zinkiewicz K; Dudka J; Klepacz R; Dabrowski A; Korobowicz E
Folia Histochem Cytobiol; 2009; 47(4):571-8. PubMed ID: 20430722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
